SOPHiA GENETICS SA (SOPH)

NASDAQ: SOPH · IEX Real-Time Price · USD
4.840
+0.020 (0.41%)
Mar 1, 2024, 4:30 PM EST - Market closed
0.41%
Market Cap 315.24M
Revenue (ttm) 58.71M
Net Income (ttm) -68.89M
Shares Out 65.03M
EPS (ttm) -1.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 43,247
Open 4.840
Previous Close 4.820
Day's Range 4.765 - 5.150
52-Week Range 2.130 - 5.840
Beta 1.16
Analysts Buy
Price Target 7.67 (+58.47%)
Earnings Date Mar 5, 2024

About SOPH

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharma customers worldwide. The company was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland. [Read more]

Sector Healthcare
IPO Date Jul 23, 2021
Employees 466
Stock Exchange NASDAQ
Ticker Symbol SOPH
Full Company Profile

Financial Performance

In 2022, SOPH's revenue was $47.56 million, an increase of 17.58% compared to the previous year's $40.45 million. Losses were -$87.45 million, 18.7% more than in 2021.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for SOPH stock is "Buy." The 12-month stock price forecast is $7.67, which is an increase of 58.47% from the latest price.

Price Target
$7.67
(58.47% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference

BOSTON and ROLLE, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Co-founder and Ch...

10 days ago - GlobeNewsWire

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024

BOSTON and ROLLE, Switzerland, Feb. 20, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release i...

12 days ago - GlobeNewsWire

SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and ROLLE, Switzerland and MADRID , Feb. 7, 2024 /PRNewswire/ -- SOPHi...

Other symbols: AZN
25 days ago - PRNewsWire

SOPHiA GENETICS Supports Genetic Testing in Brazil

The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities BOSTON and ROLLE, Switzerland , Jan. 25, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH...

5 weeks ago - PRNewsWire

SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio

RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON and ROLLE, Switzerland , Jan. 18, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software c...

6 weeks ago - PRNewsWire

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India

SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized can...

6 weeks ago - PRNewsWire

SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference

Strong SOPHiA DDM™ adoption and analysis volume contributes to continued revenue growth Liquid biopsy and HRD on SOPHiA DDM™ Platform continue to grow year-over-year, with Tennessee Oncology, Dasa and...

7 weeks ago - PRNewsWire

Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics

Insights from multimodal datasets on the platform fuel cancer research in Canada BOSTON and ROLLE, Switzerland , Jan. 8, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software co...

7 weeks ago - PRNewsWire

Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid Disorders

The Hospital will use SOPHiA GENETICS technology to streamline workflows and expedite research BOSTON and ROLLE, Switzerland , Dec. 21, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-nat...

2 months ago - PRNewsWire

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

BOSTON and ROLLE, Switzerland, Dec. 14, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (NASDAQ: SOPH) today announced that Jurgi Camblong, PhD., Chief Executive Officer and Co-founder, is scheduled to prese...

2 months ago - GlobeNewsWire

SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings

World-class liquid biopsy testing will be available to SOPHiA GENETICS customers BOSTON and ROLLE, Switzerland , Dec. 7, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software co...

3 months ago - PRNewsWire

SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes

Through the expanded relationship CHU de Nîmes will advance its research of rare and inherited diseases through pharmacogenomics BOSTON and ROLLE, Switzerland , Nov. 30, 2023 /PRNewswire/ -- SOPHiA GE...

3 months ago - PRNewsWire

SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di Torino

Largest health center in Italy uses SOPHiA DDM™ Platform on Microsoft Azure to expand data-driven medicine capabilities while ensuring accuracy and security BOSTON and ROLLE, Switzerland , Nov. 28, 20...

3 months ago - PRNewsWire

The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS

The SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and ROLLE, Switzerland , Nov. 17, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native softwa...

3 months ago - PRNewsWire

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON and ELMWOOD PARK, N.J. and ROLLE, Switzerland , Nov. 7, 2023 /PRNewswire/ -- ...

Other symbols: OPK
4 months ago - PRNewsWire

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023

BOSTON and ROLLE, Switzerland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial resul...

4 months ago - GlobeNewsWire

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023

BOSTON and GENEVA, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will relea...

4 months ago - GlobeNewsWire

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care

The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON and ROLLE, Switzerland , Oct. 18, 2023 /PRNewswire/ ...

Other symbols: AZN
4 months ago - PRNewsWire

Shaare Zedek Medical Center Uses SOPHiA GENETICS to Advance Research of Myeloid Disorders

The hospital will use the SOPHiA DDM™ Platform to further its work with myeloid disorders and advance the development of precision medicine BOSTON and ROLLE, Switzerland , Sept. 29, 2023 /PRNewswire/ ...

5 months ago - PRNewsWire

Laboratorio Curie Expands Relationship with SOPHiA GENETICS

The SOPHiA DDM™ Platform will help Laboratorio Curie advance its research into BRCA gene mutations BOSTON and ROLLE, Switzerland , Sept. 13, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a clou...

6 months ago - PRNewsWire

SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform

With the help of the SOPHiA DDM™ Platform, IRST has introduced a new diagnostic kit that will support data- driven treatment planning for a dvanced ovarian cancer BOSTON and ROLLE, Switzerland , Sept....

6 months ago - PRNewsWire

CHU Bordeaux is live on SOPHiA GENETICS

The hospital is using the SOPHiA DDM™ Platform to advance the research of Homologous  Recombinati on Repair Mutated Cancers BOSTON and ROLLE, Switzerland , Aug. 30, 2023 /PRNewswire/ -- SOPHiA GENETIC...

6 months ago - PRNewsWire

SOPHiA GENETICS Expands Relationship with Gustave Roussy

Gustave Roussy uses SOPHiA DDM™ Platform to empower confident, data-driven medicine in the fight against cancer BOSTON and ROLLE, Switzerland , Aug. 22, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: S...

6 months ago - PRNewsWire

A.O.U. San Giovanni di Dio Ruggi d'Aragona Expands Usage of SOPHiA GENETICS DDM™ Platform

The Hospital will use the SOPHiA DDM™ Platform to advance its research and diagnosis of blood cancers BOSTON and ROLLE, Switzerland , Aug. 17, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cl...

7 months ago - PRNewsWire

SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023

BOSTON and ROLLE, Switzerland, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial resul...

7 months ago - GlobeNewsWire